APTARGROUP INC (ATR)       97.095  -0.31 (-0.32%)

97.095  -0.31 (-0.32%)

US0383361039 - Common Stock


Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ATR. ATR was compared to 28 industry peers in the Containers & Packaging industry. ATR has a great financial health rating, but there are some minor concerns on its profitability. While showing a medium growth rate, ATR is valued expensive at the moment.




Profitability

Profitability Rating

4

ATR's Return On Assets of 5.42% is amongst the best of the industry. ATR does better than the industry average Return On Assets of 4.68%.
ATR has a Profit Margin of 6.94%. This is better than the industry average of 5.93%.

The Piotroski-F score of ATR is 5.00. This is a neutral score and indicates average health and profitability for ATR.
ATR's Return On Equity of 11.94% is worse than the rest of the industry. The industry average Return On Equity is 20.37%.
VS Industry

ROA (5.42%) VS Industry: 62% outperformed.

-29.40
12.26

ROE (11.94%) VS Industry: 31% outperformed.

6.60
276.26

Profit Margin (6.94%) VS Industry: 68% outperformed.

-7.80
12.15

Valuation

Valuation Rating

0

With a Forward Price/Earnings Ratio of 22.54, ATR is valued rather expensively.
When comparing the current price to the book value of ATR, we can conclude it is valued correctly. It is trading at 3.28 times its book value.
The Price/Earnings Ratio is 25.62, which means the current valuation is very expensive for ATR.
With a Price/Earning Ratio of 25.62, ATR is valued a higher than the industry average, which is at 10.82. 100% of the companies listed in the same industry are cheaper than ATR!

The high PEG Ratio, which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
When comparing the price book ratio of ATR to the average industry price book ratio of 2.57, ATR is valued more expensive than its industry peers.
Compared to an average industry Enterprise Value to EBITDA ratio of 8.70, ATR is valued more expensive than its industry peers. 93% of the companies listed in the same industry are valued cheaper.
VS Industry

Price/Earnings (25.62) VS Industry: 0% outperformed.

25.62
5.62

Price/Book (3.28) VS Industry: 25% outperformed.

32.34
0.44

Enterprise Value/ EBITDA (12.05) VS Industry: 7% outperformed.

13.59
0.79

Growth

Growth Rating

4

When comparing the EPS growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
The earnings per share for ATR have decreased by -3.32% in the last year.
Measured over the past 5 years, ATR shows a small growth in Earnings Per Share. The EPS has been growing by 4.34% on average per year.
Based on estimates for the next 5 years, ATR will show a small growth in Earnings Per Share. The EPS will grow by 9.54% on average per year.

The Revenue has been growing slightly by 7.51% in the past year.
Measured over the past 5 years, ATR shows a small growth in Revenue. The Revenue has been growing by 6.72% on average per year.
The Revenue is expected to grow by 4.76% on average over the next 5 years.
The Revenue growth is decreasing: in the next 5 years the growth will be less than in the last years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS4.34% -1.01% -3.32% 0.45% 5.51% 8.14% 9.54%
Revenue6.72% 5.29% 7.51% 4.88% 4.2% 4.95% 4.76%

Health

Health Rating

7

When comparing the Current Ratio to an average industry Current Ratio of 1.62, ATR is better placed than the average industry peer to meet its short term obligations.
ATR is better placed than average in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 1.05.
The Debt to Equity ratio of ATR is way better than the industry averages.
An Altman-Z score of 3.54 indicates that ATR is not in any danger for bankruptcy at the moment.

The Altman-Z score of ATR is much better than the industry average of 2.07. ATR has a better rating than 85% of its industry peers.
A Current Ratio of 1.90 indicates that ATR should not have too much problems paying its short term obligations.
ATR has a Quick Ratio of 1.32. This is a normal value and indicates that ATR is financially healthy and should not expect problems in meeting its short term obligations.
The Piotroski-F score of ATR is 5.00. This is a neutral score and indicates average health and profitability for ATR.
VS Industry

Debt/Equity (0.66) VS Industry: 66% outperformed.

18.30
0.00

Quick Ratio (1.32) VS Industry: 77% outperformed.

0.54
16.50

Current Ratio (1.9) VS Industry: 70% outperformed.

0.95
16.50

Altman-Z (3.54) VS Industry: 85% outperformed.

-0.06
7.53

Dividend

Dividend Rating

5

ATR's earnings are growing more than its dividend. This makes the dividend growth sustainable.
ATR has paid a dividend for at least 10 years, which is a reliable track record.
With a Yearly Dividend Yield of 1.48%, ATR has a reasonable but not impressive dividend return.
The dividend of ATR has a limited annual growth rate of 4.35%.

ATR pays out 43.27% of its income as dividend. This is a bit on the high side, but may be sustainable.
ATR's Dividend Yield is slightly below the industry average, which is at 3.02.
With a Dividend Yield of 1.48, ATR pays less dividend than the S&P500 average, which is at 2.48.
VS Industry

Dividend Yield (1.48%) VS Industry: 31% outperformed.

0.27
13.47
ATR Daily chart

APTARGROUP INC97.095

NYSE:ATR (9/27/2022, 9:19:37 AM)-0.31 (-0.32%)

Chartmill FA Rating
GICS Sector Materials
GICS IndustryGroup Materials
GICS Industry Containers & Packaging
Earnings (Last) 07-28 2022-07-28/amc Earnings (Next) 10-27 2022-10-27
Ins Owners 0.6% Inst Owners 88.61%
Market Cap 6.34B Analysts 72.86
Valuation
PE 25.62 Fwd PE 22.54
PEG (NY) 57.05 PEG (5Y) 5.91
P/S 1.91 P/B 3.28
EV/EBITDA 12.05
Dividend
Dividend Yield 1.48% Dividend Growth 4.35%
DP 43.27% Ex-Date 07-26 2022-07-26 (0.38)
Growth
EPS 1Y -3.32% EPS 3Y -1.01%
EPS 5Y 4.34% EPS growth Q2Q 5.49%
EPS Next Y 0.45% EPS Next 2Y 5.51%
EPS Next 3Y 8.14% EPS Next 5Y 9.54%
Revenue growth 1Y 7.51% Revenue growth 3Y 5.29%
Revenue growth 5Y 6.72% Revenue growth Q2Q 4.13%
Revenue Next Year 4.88% Revenue Next 2Y 4.2%
Revenue Next 3Y 4.95% Revenue Next 5Y 4.76%
Health
Current Ratio 1.9 Quick Ratio 1.32
Altman-Z 3.54 F-Score 5
Debt/Equity 0.66
Profitability
ROA 5.42% ROE 11.94%
ROIC 13.04% ROICg 8.24%
PM 6.94 OM 11.6
Asset Turnover 0.78

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA